Here, we used genome-wide molecular profiling to comprehensively investigate the relationship between RA-associated genetic variants, DNAm, and gene expression in primary CD4+ T and B cells of drug-naive patients with early arthritis. This evidence concerns the gene CD4 and arthritic joint disease.